Literature DB >> 13122659

Deoxyribonuclease in the treatment of purulent bronchitis.

P C ELMES, J C WHITE.   

Abstract

Entities:  

Keywords:  BRONCHITIS/therapy; NUCLEASES

Mesh:

Substances:

Year:  1953        PMID: 13122659      PMCID: PMC1019278          DOI: 10.1136/thx.8.4.295

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  4 in total

1.  Trypsin in poliomyelitis patients with tracheotomy.

Authors:  A J STEIGMAN; C H SCOTT
Journal:  J Am Med Assoc       Date:  1952-12-06

2.  Enzymatic lysis of respiratory secretions by aerosol trypsin.

Authors:  C R LIMBER; H G REISER; L C ROETTIG; G M CURTIS
Journal:  J Am Med Assoc       Date:  1952-06-28

3.  Liquefaction of viscous purulent exudates by deoxyribonuclease.

Authors:  J B ARMSTRONG; J C WHITE
Journal:  Lancet       Date:  1950-12-09       Impact factor: 79.321

4.  Refinements in polarized light microscopy.

Authors:  M M SWANN; J M MITCHISON
Journal:  J Exp Biol       Date:  1950-09       Impact factor: 3.312

  4 in total
  10 in total

1.  Cytological examination of sputum in relation to its macroscopic purulence.

Authors:  G A RAWLINS
Journal:  J Clin Pathol       Date:  1955-05       Impact factor: 3.411

2.  The intravenous injection of bovine crystalline pancreatic desoxyribonuclease into patients.

Authors:  A J JOHNSON; P R GOGER; W S TILLETT
Journal:  J Clin Invest       Date:  1954-12       Impact factor: 14.808

3.  Value of ampicillin in the hospital treatment of exacerbations of chronic bronchitis.

Authors:  P C Elmes; T K King; J H Langlands; J A Mackay; W F Wallace; O L Wade; T S Wilson
Journal:  Br Med J       Date:  1965-10-16

Review 4.  The role of recombinant human DNase in the treatment of patients with cystic fibrosis: many promises, more problems.

Authors:  M S Zach
Journal:  Thorax       Date:  1996-07       Impact factor: 9.139

5.  rhDNase in cystic fibrosis.

Authors:  S P Range; A J Knox
Journal:  Thorax       Date:  1995-04       Impact factor: 9.139

Review 6.  New respiratory therapies in cystic fibrosis.

Authors:  D E Stableforth
Journal:  J R Soc Med       Date:  1994       Impact factor: 5.344

7.  Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum.

Authors:  S Shak; D J Capon; R Hellmiss; S A Marsters; C L Baker
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

8.  Bacteriological and biochemical criteria for the diagnosis of bacterial infections in chronic obstructive pulmonary disease (COPD).

Authors:  K Bartmann; M Fooke-Achterrath; G Koch; I Schütz; M Zierski
Journal:  Infection       Date:  1984 Mar-Apr       Impact factor: 3.553

9.  Clinical and physiological evaluation of mucolytic agents nebulized with soproterenol: 10 per cent N-acetylcysteine verus 10 per cent 2-mercaptoethane sulphonate.

Authors:  S R Hirsch; P F Viernes; R C Kory
Journal:  Thorax       Date:  1970-11       Impact factor: 9.139

10.  Infections in cystic fibrosis.

Authors:  Kathy A Marks-Austin; Stanley B Fiel; Preston W Campbell; Terrence L Stull
Journal:  Semin Pediatr Infect Dis       Date:  2006-05-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.